Device General and Plastic Surgery

Cortiva Allograft Dermis

Payments companies reported to CMS as associated with Cortiva Allograft Dermis. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$2.4Massociated payments (2023-2025)
801clinicians with associated payments
2companies reporting

By year

2023 $422K
2024 $1.0M
2025 $947K

Payments reported as associated with Cortiva Allograft Dermis, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Plastic Surgery $1.5M
Plastic and Reconstructive Surgery $459K
Blood Banking & Transfusion Medicine $277K
Anatomic Pathology & Clinical Pathology $91K
Surgery $48K
Surgery of The Hand (Surgery) $9,641

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Cortiva Allograft Dermis

These are the largest totals companies reported as associated with Cortiva Allograft Dermis. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Suhail Kanchwala Philadelphia, PA Plastic Surgery $741,977.40
Marek Fried Gainesville, FL Blood Banking & Transfusion Medicine $277,380.00
Luther Holton Wilmington, NC Plastic Surgery $190,015.76
Albert Losken Atlanta, GA Plastic Surgery $107,039.56
Terence Myckatyn Saint Louis, MO Plastic and Reconstructive Surgery $98,244.55
Sharon Hook Gainesville, FL Anatomic Pathology & Clinical Pathology $90,580.00
John Murray Jacksonville, FL Plastic and Reconstructive Surgery $80,626.41
Alireza Tehrani Apple Valley, CA Plastic Surgery $80,626.41
Randal Rudderman Alpharetta, GA Plastic and Reconstructive Surgery $80,626.41
Fares Samra Holmdel, NJ Plastic Surgery $33,790.94

Prescribed Cortiva Allograft Dermis?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.